SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Syneos Health, Inc. – ‘8-K/A’ for 1/21/21

On:  Monday, 3/8/21, at 5:05pm ET   ·   For:  1/21/21   ·   Accession #:  1564590-21-11520   ·   File #:  1-36730

Previous ‘8-K’:  ‘8-K’ on 3/3/21 for 2/26/21   ·   Next:  ‘8-K’ on / for 4/29/21   ·   Latest:  ‘8-K’ on 5/5/21 for 4/30/21   ·   1 Reference:  By:  Syneos Health, Inc. – ‘424B7’ on 5/5/21

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/08/21  Syneos Health, Inc.               8-K/A:5     1/21/21   10:157K                                   ActiveDisclosure/FA

Amendment to Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     29K 
 6: R1          Document and Entity Information                     HTML     48K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 5: XML         XBRL Instance -- synh-8ka_20210121_htm               XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- synh-20210121_lab                     XML     58K 
 4: EX-101.PRE  XBRL Presentations -- synh-20210121_pre              XML     35K 
 2: EX-101.SCH  XBRL Schema -- synh-20210121                         XSD     18K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
10: ZIP         XBRL Zipped Folder -- 0001564590-21-011520-xbrl      Zip      9K 

‘8-K/A’   —   Amendment to Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:   C:   C:   C:   C:   C: 
 i true  i 0001610950 0001610950 2021-01-21 2021-01-21






FORM  i 8-K/A



Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i January 21, 2021



(Exact name of registrant as specified in its charter)



 i Delaware

 i 001-36730

 i 27-3403111

(State or other jurisdiction
of incorporation)

File Number)

(IRS Employer
Identification No.)


 i 1030 Sync Street

 i Morrisville,  i North Carolina

 i 27560-5468

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: ( i 919)  i 876-9300



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class


Trading Symbol(s)


Name of each exchange on which registered


Class A Common Stock,
$0.01 par value per share




 i The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i    

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section

13(a) of the Exchange Act.  





 i On January 21, 2021, Syneos Health, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) to report, among other items, the appointment of Donna Kralowetz as the Company’s Chief Accounting Officer and principal accounting officer, in each case effective January 27, 2021. Pursuant to Instruction 2 to Item 5.02 of Form 8-K, this Form 8-K/A is being filed solely to report information called for in Item 5.02(c)(3) of Form 8-K that had not been determined at the time of the filing of the Original Filing.


Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 2, 2021, the Compensation and Management Development Committee of the Board of Directors of the Company approved, among other changes, a one-time $100,000 grant of time-based restricted stock units pursuant to the Company’s 2018 Equity Incentive Plan to Ms. Kralowetz in connection with her appointment as the Company’s Chief Accounting Officer. The award will vest in three approximately equal annual installments on the first three anniversaries of the date of grant, subject to her continued employment with the Company.




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.












March 8, 2021


/s/ Jason Meggs





Jason Meggs





Chief Financial Officer (Principal Financial Officer)



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K/A’ Filing    Date    Other Filings
Filed on:3/8/21
1/27/213,  4
For Period end:1/21/218-K
 List all Filings 

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/05/21  Syneos Health, Inc.               424B7                  1:398K                                   Donnelley … Solutions/FA
Filing Submission 0001564590-21-011520   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 14, 11:54:53.0am ET